CDK8/19 inhibition overcomes in vitro and in vivo resistance to lapatinib in HER2+breast cancer via STAT1 and STAT3.

被引：0

作者：

Ding, Xiaokai ^{[1
]}

Sharko, Amanda C. ^{[1
]}

McDermott, Martina S-J ^{[1
]}

Ji, Hao ^{[1
]}

Chumanevich, Alexander ^{[1
]}

Schools, Gary P. ^{[1
]}

Mack, Zachary T. ^{[1
]}

Pugacheva, Elena ^{[2
]}

Tatarskiy, Victor ^{[3
]}

Khrustaleva, Anastasia ^{[3
]}

Tyakht, Alexander ^{[3
]}

Shtutman, Michael ^{[1
]}

Chen, Mengqian ^{[4
]}

Roninson, Igor ^{[1
]}

Broude, Eugenia V. ^{[1
]}

机构：

[1] Univ South Carolina, Coll Pharm, Columbia, SC 29208 USA

[2] West Virginia Univ, Sch Med, Morgantown, WV 26506 USA

[3] Russian Acad Sci, Inst Gene Biol, Moscow, Russia

[4] Senex Biotechnol, Columbia, SC USA

来源：

CANCER RESEARCH | 2021年 / 81卷 / 13期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB132

引用

页数：2

共 50 条

[21] Inhibition of the autocrine IL6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+breast cancers
Silva, J.
Rodriguez-Barrueco, R.
Yu, J.
Kalinsky, K.
Maurer, M.
Califano, A.
CANCER RESEARCH, 2016, 76
[22] Evaluating the role of CDK4/6 inhibition on STAT3 activation in a transgenic mouse model of HER2-positive breast cancer
Adesoye, Taiwo
Luo, Linjie
Bui, Tuyen
Kim, Serena
Wingate, Hannah
Tripathy, Debu
Hunt, Kelly
Keyomarsi, Khandan
CANCER RESEARCH, 2024, 84 (09)
[23] Pharmacological Inhibition of CDK8 in Triple-Negative Breast Cancer Cell Line MDA-MB-468 Increases E2F1 Protein, Induces Phosphorylation of STAT3 and Apoptosis
Spear, Jensen M.
Lu, Zhixin
Russu, Wade A.
MOLECULES, 2020, 25 (23):
[24] IL-8 secreted by tumor associated macrophages contribute to lapatinib resistance in HER2-positive locally advanced breast cancer via activation of Src/STAT3/ERK1/2-mediated EGFR signaling
Ahmed, Shaza
Mohamed, Hossam Taha
El-Husseiny, Noura
El Mahdy, Manal M.
Safwat, Gehan
Diab, Ayman A.
El-Sherif, Ahmed A.
El-Shinawi, Mohamed
Mohamed, Mona Mostafa
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2021, 1868 (06):
[25] Inhibition of the JAK2/STAT3 Pathway Reduces Gastric Cancer Growth In Vitro and In Vivo
Judd, Louise M.
Menheniott, Treve R.
Ling, Hui
Jackson, Cameron B.
Howlett, Meegan
Kalantzis, Anastasia
Priebe, Waldemar
Giraud, Andrew S.
PLOS ONE, 2014, 9 (05):
[26] MiR-382-5p suppresses M1 macrophage polarization and inflammatory response in response to bronchopulmonary dysplasia through targeting CDK8: Involving inhibition of STAT1 pathway
Lv, Yuanyuan
Li, Yang
Wang, Jiangya
Li, Mei
Zhang, Wenhao
Zhang, Huifen
Shen, Ying
Li, Chao
Du, Yuan
Jiang, Lian
GENES TO CELLS, 2021, 26 (10) : 772 - 781
[27] NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer
Lili Jiang
Liangliang Ren
Han Chen
Jinyuan Pan
Zhuojun Zhang
Xiangqin Kuang
Xuhong Chen
Wenhao Bao
Chun Lin
Zhongqiu Zhou
Danping Huang
Jianan Yang
Hongbiao Huang
Lan Wang
Ning Hou
Libing Song
Cell Death & Disease, 11
[28] NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer
Jiang, Lili
Ren, Liangliang
Chen, Han
Pan, Jinyuan
Zhang, Zhuojun
Kuang, Xiangqin
Chen, Xuhong
Bao, Wenhao
Lin, Chun
Zhou, Zhongqiu
Huang, Danping
Yang, Jianan
Huang, Hongbiao
Wang, Lan
Hou, Ning
Song, Libing
CELL DEATH & DISEASE, 2020, 11 (07)
[29] PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer
Zhang, Hongyan
Zhang, Longlong
He, Yuna
Jiang, Dewei
Sun, Jian
Luo, Qianmei
Liang, Huichun
Wang, Tiantian
Li, Fubing
Tang, Yu
Yang, Zimo
Liu, Wenjing
Rao, Yu
Chen, Ceshi
CANCER LETTERS, 2024, 598
[30] Functionalized nanoscale β-1,3-glucan to improve Her2+breast cancer therapy: In vitro and in vivo study
Nasrollahi, Zahra
Mohammadi, Shahla Roudbar
Mollarazi, Esmail
Yadegari, Mohammad Hossein
Hassan, Zuhair Mohammad
Talaei, Fatemeh
Dinarvand, Rassoul
Akbari, Hassan
Atyabi, Fatemeh
JOURNAL OF CONTROLLED RELEASE, 2015, 202 : 49 - 56

← 1 2 3 4 5 →